文献速递产科母胎医学

产前激素疗效差异与母胎血浆药物水平无关:绵羊妊娠模型证据

Variability in the efficacy of a standardized antenatal steroid treatment was independent of maternal or fetal plasma drug levels: evidence from a sheep model of pregnancy.
PubMed 文献 · Am J Obstet Gynecol · 2020-05-21

该研究用慢性导管绵羊妊娠模型,将孕羊随机分为生理盐水对照组(n=10)和单次肌注0.25 mg/kg倍他米松磷酸酯加醋酸盐组(n=20),检测母胎血浆倍他米松浓度并评估早产羔羊通气30分钟时的肺成熟度。产前激素组约40%羔羊肺成熟度与盐水对照组无显著差异,且应答者与非应答者的倍他米松分布、清除或蛋白结合无差异。

要点

  • 产前激素组中约40%早产羔羊肺成熟度与盐水对照组无显著差异。
  • 应答者与非应答者的母胎倍他米松暴露量、分布、清除及蛋白结合无差异。
  • 产前激素疗效不完全由母胎药物水平决定,个体胎儿或母体因素可能参与。

核心结论

  • 产前激素治疗 efficacy 的个体差异不单纯由母胎倍他米松暴露水平决定。

研究设计与样本

  • 慢性导管绵羊妊娠模型,孕119天手术置管,恢复24小时后随机分组。
  • 对照组单次肌注2 mL生理盐水(n=10),产前激素组单次肌注0.25 mg/kg倍他米松磷酸酯加醋酸盐(n=20)。
  • 给药48小时后采集母胎系列血浆样本,分娩后羔羊通气30分钟,用质谱法测总及游离倍他米松浓度。

主要发现

  • 产前激素组19只中12只为应答者、7只为非应答者(以通气30分钟动脉血CO2分压位于盐水对照组均值2个标准差内为界)。
  • 产前激素整体及应答者亚组在生理和生化指标上均显示肺成熟改善,但非应答者亚组与盐水对照组相比无改善。
  • 应答者与非应答者之间倍他米松分布、清除或蛋白结合无差异。

关键数值与推荐

  • 应答判定标准:通气30分钟动脉血CO2分压位于盐水对照组均值2个标准差内。
  • 产前激素组约40%早产羔羊肺成熟度与盐水对照组无显著差异。

临床怎么用

  • 临床解读产前激素疗效差异时,需考虑药物暴露水平之外的因素。
  • 对产前激素非应答者,应关注个体胎儿或母体因素对糖皮质激素信号反应的影响。

局限性

  • 本研究为绵羊妊娠模型,结果外推到人类需谨慎。
  • 对照组和产前激素组各1只未完成方案被剔除分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Administration of antenatal steroids is standard of care for women assessed to be at imminent risk of preterm delivery. There is a marked variation in antenatal steroid dosing strategy, selection for treatment criteria, and agent choice worldwide. This, combined with very limited optimization of antenatal steroid use per se, means that treatment efficacy is highly variable, and the rate of respiratory distress syndrome is decreased to perhaps as low as 40%. In some cases, antenatal steroid use is associated with limited benefit and potential harm. OBJECTIVE: We hypothesized that individual differences in maternofetal steroid exposure would contribute to observed variability in antenatal steroid treatment efficacy. Using a chronically catheterized sheep model of pregnancy, we aimed to explore the relationship between maternofetal steroid exposure and antenatal steroid treatment efficacy as determined by functional lung maturation in preterm lambs undergoing ventilation. STUDY DESIGN: Ewes carrying a single fetus underwent surgery to catheterize a fetal and maternal jugular vein at 119 days' gestation. Animals recovered for 24 hours before being randomized to either (1) a single maternal intramuscular injection of 2 mL saline (negative control group, n=10) or (2) a single maternal intramuscular injection of 0.25 mg/kg betamethasone phosphate plus acetate (antenatal steroid group, n=20). Serial maternal and fetal plasma samples were collected from each animal after 48 hours before fetuses were delivered and ventilated for 30 minutes. Total and free plasma betamethasone concentration was measured by mass spectrometry. Fetal lung tissue was collected for analysis using quantitative polymerase chain reaction. RESULTS: One animal from the control group and one animal from the antenatal steroid group did not complete their treatment protocol and were removed from analyses. Animals in the antenatal steroid group were divided into a responder subgroup (n=12/19) and a nonresponder subgroup (n=7/19) using a cutoff of partial pressure of arterial CO2 at 30-minute ventilation within 2 standard deviations of the mean value from saline-treated negative control group animals. Although antenatal steroid improved fetal lung maturation in the undivided antenatal steroid group and in the responder subgroup both physiologically (blood gas- and ventilation-related data) and biochemically (messenger ribonucleic acid expression related to fetal lung maturation), these values did not improve relative to saline-treated control group animals in the antenatal steroid nonresponder subgroup. No differences in betamethasone distribution, clearance, or protein binding were identified between the antenatal steroid responder and nonresponder subgroups. CONCLUSION: This study correlated individual maternofetal steroid exposures with preterm lung maturation as determined by pulmonary ventilation. Herein, approximately 40% of preterm lambs exposed to antenatal steroids had lung maturation that was not significantly different to saline-treated control group animals. These nonresponsive animals received maternal and fetal betamethasone exposures identical to animals that had a significant improvement in functional lung maturation. These data suggest that the efficacy of antenatal steroid therapy is not solely determined by maternofetal drug levels and that individual fetal or maternal factors may play a role in determining treatment outcomes in response to glucocorticoid signaling.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Takahashi T, Saito M, Schmidt AF, et al. Variability in the efficacy of a standardized antenatal steroid treatment was independent of maternal or fetal plasma drug levels: evidence from a sheep model of pregnancy. Am J Obstet Gynecol. 2020. PMID: 32445634. doi:10.1016/j.ajog.2020.05.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。